11.07.2015 Views

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSC8.6 Screen<strong>in</strong>g ToolsThe TST us<strong>in</strong>g <strong>the</strong> Mantoux technique (2TU) is <strong>the</strong> primary tool used <strong>in</strong> c<strong>on</strong>tact trac<strong>in</strong>g 295 (chapter 2). IGRAtest<strong>in</strong>g is an additi<strong>on</strong>al diagnostic method for screen<strong>in</strong>g <strong>of</strong> LTBI.Guides to evaluat<strong>in</strong>g c<strong>on</strong>tacts <strong>of</strong> active TB cases are shown <strong>in</strong> figures 8.1 (for c<strong>on</strong>tacts <strong>of</strong> active TB cases)<strong>and</strong> 8.2 (for children between four weeks <strong>and</strong> five years who are c<strong>on</strong>tacts <strong>of</strong> <strong>in</strong>fectious TB cases). Theseguidel<strong>in</strong>es do not fit every circumstance <strong>and</strong> additi<strong>on</strong>al c<strong>on</strong>siderati<strong>on</strong>s bey<strong>on</strong>d those discussed <strong>in</strong> <strong>the</strong>seguidel<strong>in</strong>es may need to be taken <strong>in</strong>to account for specific situati<strong>on</strong>s. It is important to m<strong>on</strong>itor attendance,to identify those c<strong>on</strong>tacts who fail to attend <strong>and</strong> to ensure that <strong>the</strong> c<strong>on</strong>tact’s GP is <strong>in</strong>formed <strong>of</strong> repeatedfailures to attend.In <strong>the</strong> future, <strong>the</strong> rapidly exp<strong>and</strong><strong>in</strong>g evidence base will provide more reliable <strong>in</strong>formati<strong>on</strong> <strong>on</strong> <strong>the</strong> sensitivity<strong>and</strong> specificity <strong>of</strong> IGRA tests <strong>and</strong> <strong>the</strong>ir comparability to <strong>the</strong> TST. Evidence ga<strong>the</strong>red to date suggests that<strong>the</strong> IGRA tests are at least as sensitive as <strong>the</strong> TST <strong>in</strong> diagnos<strong>in</strong>g LTBI <strong>and</strong> more specific <strong>in</strong> populati<strong>on</strong>s that<strong>in</strong>clude previously BCG vacc<strong>in</strong>ated <strong>in</strong>dividuals. However, discordant results between IGRA <strong>and</strong> <strong>the</strong> TSThave been observed, lead<strong>in</strong>g to difficulties <strong>in</strong>terpret<strong>in</strong>g <strong>the</strong> results. 60In <strong>the</strong>ory, a two-step strategy, us<strong>in</strong>g TST (with its high sensitivity) followed by IGRA test<strong>in</strong>g (with its highspecificity) should be an optimal approach for screen<strong>in</strong>g an <strong>in</strong>dividual exposed to a TB case. 26 The chestX-ray is generally reserved as a means <strong>of</strong> c<strong>on</strong>firm<strong>in</strong>g pulm<strong>on</strong>ary disease follow<strong>in</strong>g recent c<strong>on</strong>tact with TB or<strong>in</strong> <strong>the</strong> presence <strong>of</strong> suggestive symptoms.Canadian guidel<strong>in</strong>es 60;296 <strong>on</strong> IGRA published <strong>in</strong> 2007 <strong>and</strong> updated <strong>in</strong> 2008 summarised current evidence <strong>in</strong><strong>the</strong> c<strong>on</strong>text <strong>of</strong> c<strong>on</strong>tacts <strong>of</strong> a case <strong>of</strong> <strong>in</strong>fectious TB <strong>and</strong> IGRA use as follows:• IGRA correlated with exposure better than TST <strong>in</strong> BCG vacc<strong>in</strong>ated c<strong>on</strong>tacts. There weresignificantly fewer positive results <strong>in</strong> low-exposure groups with <strong>the</strong> IGRA than with <strong>the</strong> TST• In <strong>the</strong> absence <strong>of</strong> BCG, <strong>the</strong> IGRA <strong>and</strong> TST appeared to have similar rates <strong>of</strong> positivity, although<strong>the</strong>re were discordant results.Those guidel<strong>in</strong>es c<strong>on</strong>clude that, given that several studies have found significant discordance between TST<strong>and</strong> IGRA results (both TST positive/IGRA negative <strong>and</strong> <strong>the</strong> reverse) <strong>and</strong> because <strong>the</strong> biological basis <strong>of</strong> thisdiscordance is uncerta<strong>in</strong>, <strong>the</strong> reliance <strong>on</strong> IGRA should depend <strong>on</strong> <strong>the</strong> cl<strong>in</strong>ical c<strong>on</strong>text.The Canadian guidance with regard to IGRA use <strong>in</strong> c<strong>on</strong>tact trac<strong>in</strong>g is recommended.Canadian guidance <strong>on</strong> IGRA for adult <strong>and</strong> child c<strong>on</strong>tacts <strong>of</strong> a case <strong>of</strong> active <strong>in</strong>fectious TBtuberculosis 60IGRA may be used as a c<strong>on</strong>firmatory test for a positive TST <strong>in</strong> c<strong>on</strong>tacts (adult or child) who <strong>on</strong><strong>the</strong> basis <strong>of</strong> an assessment <strong>of</strong> <strong>the</strong> durati<strong>on</strong> <strong>and</strong> degree <strong>of</strong> c<strong>on</strong>tact with an active <strong>in</strong>fectious caseare felt to have a low pre-test probability <strong>of</strong> recently acquired LTBI <strong>and</strong> who have no o<strong>the</strong>rhigh or <strong>in</strong>creased risk factors for progressi<strong>on</strong> to active disease if <strong>in</strong>fected.For close c<strong>on</strong>tacts or those c<strong>on</strong>tacts who have high or <strong>in</strong>creased risk <strong>of</strong> progressi<strong>on</strong> to activedisease if <strong>in</strong>fected, a TST (or both TST <strong>and</strong> IGRA) should be used <strong>and</strong> if ei<strong>the</strong>r is positive <strong>the</strong>c<strong>on</strong>tact should be c<strong>on</strong>sidered to have LTBI.If both TST <strong>and</strong> IGRA test<strong>in</strong>g will be used, it is recommended that blood be drawn for IGRA <strong>on</strong>or before <strong>the</strong> day when <strong>the</strong> TST is read.Repeat<strong>in</strong>g TST <strong>in</strong> c<strong>on</strong>tact <strong>in</strong>vestigati<strong>on</strong>sThe <strong>in</strong>terval between acquisiti<strong>on</strong> <strong>of</strong> <strong>in</strong>fecti<strong>on</strong> <strong>and</strong> tubercul<strong>in</strong> c<strong>on</strong>versi<strong>on</strong> is an important issue. Thisdeterm<strong>in</strong>es <strong>the</strong> <strong>in</strong>terval between <strong>the</strong> first <strong>and</strong> sec<strong>on</strong>d TST <strong>in</strong> c<strong>on</strong>tact <strong>in</strong>vestigati<strong>on</strong>s i.e. <strong>the</strong> so-calledw<strong>in</strong>dow period. Traditi<strong>on</strong>ally this had been c<strong>on</strong>sidered to be 12 weeks but all available evidence from-100-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!